Quipazine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Quipazine" in English language version.

refsWebsite
Global rank English rank
2nd place
2nd place
4th place
4th place
3rd place
3rd place
5th place
5th place
1,538th place
1,042nd place
low place
low place
800th place
676th place

bindingdb.org

books.google.com

doi.org

  • Glennon RA, Dukat M (2 May 2023). "Quipazine: Classical hallucinogen? Novel psychedelic?". Australian Journal of Chemistry. 76 (5): 288–298. doi:10.1071/CH22256. ISSN 0004-9425.
  • Cappelli A, Butini S, Brizzi A, Gemma S, Valenti S, Giuliani G, et al. (2010). "The interactions of the 5-HT3 receptor with quipazine-like arylpiperazine ligands: the journey track at the end of the first decade of the third millennium". Curr Top Med Chem. 10 (5): 504–526. doi:10.2174/156802610791111560. PMID 20166948.
  • de la Fuente Revenga M, Shah UH, Nassehi N, Jaster AM, Hemanth P, Sierra S, et al. (March 2021). "Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice". ACS Chem Neurosci. 12 (5): 831–844. doi:10.1021/acschemneuro.0c00291. PMC 7933111. PMID 33400504.
  • Rodríguez R, Pardo EG (1971). "Quipazine, a new type of antidepressant agent". Psychopharmacologia. 21 (1): 89–100. doi:10.1007/BF00404000. PMID 5567294.
  • Glennon RA (1996). "Classical Hallucinogens". Pharmacological Aspects of Drug Dependence. Vol. 118. Berlin, Heidelberg: Springer Berlin Heidelberg. p. 343–371. doi:10.1007/978-3-642-60963-3_10. ISBN 978-3-642-64631-7.
  • Glennon RA (1988). "Site-Selective Serotonin Agonists as Discriminative Stimuli". Transduction Mechanisms of Drug Stimuli. Berlin, Heidelberg: Springer Berlin Heidelberg. p. 15–31. doi:10.1007/978-3-642-73223-2_2. ISBN 978-3-642-73225-6.
  • Nakagawasai O, Arai Y, Satoh SE, Satoh N, Neda M, Hozumi M, et al. (January 2004). "Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives". Neurotoxicology. 25 (1–2): 223–232. doi:10.1016/S0161-813X(03)00101-3. PMID 14697897.
  • Halberstadt AL, Geyer MA (2016). "Effect of Hallucinogens on Unconditioned Behavior". Current Topics in Behavioral Neurosciences. 36: 159–199. doi:10.1007/7854_2016_466. ISBN 978-3-662-55878-2. PMC 5787039. PMID 28224459.
  • Young R, Glennon RA (1986). "Discriminative stimulus properties of amphetamine and structurally related phenalkylamines". Med Res Rev. 6 (1): 99–130. doi:10.1002/med.2610060105. PMID 3512936.
  • Glennon RA, Rosecrans JA (1981). "Speculations on the mechanism of action of hallucinogenic indolealkylamines". Neurosci Biobehav Rev. 5 (2): 197–207. doi:10.1016/0149-7634(81)90002-6. PMID 7022271.
  • Goudie AJ (September 1985). "Comparative effects of cathinone and amphetamine on fixed-interval operant responding: a rate-dependency analysis". Pharmacol Biochem Behav. 23 (3): 355–365. doi:10.1016/0091-3057(85)90006-1. PMID 4048231.

espacenet.com

worldwide.espacenet.com

  • DE 2006638, Rodriguez R, issued 1970  Chem. Abstr., 73: 98987g (1970).

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

unc.edu

pdsp.unc.edu

worldcat.org

search.worldcat.org

  • Glennon RA, Dukat M (2 May 2023). "Quipazine: Classical hallucinogen? Novel psychedelic?". Australian Journal of Chemistry. 76 (5): 288–298. doi:10.1071/CH22256. ISSN 0004-9425.